Literature DB >> 19651757

Discontinuation of quetiapine from an NIMH-funded trial due to serious adverse events.

Dilip V Jeste, Hua Jin, Shahrokh Golshan, Sunder Mudaliar, Danielle Glorioso, Ian Fellows, Helena Kraemer, Stephan Arndt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19651757     DOI: 10.1176/appi.ajp.2009.09040501

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  5 in total

1.  Dispensed prescriptions for quetiapine and other second-generation antipsychotics in Canada from 2005 to 2012: a descriptive study.

Authors:  Tamara Pringsheim; David M Gardner
Journal:  CMAJ Open       Date:  2014-10-01

Review 2.  Late-onset schizophrenia: do recent studies support categorizing LOS as a subtype of schizophrenia?

Authors:  Jeanne E Maglione; Scot E Thomas; Dilip V Jeste
Journal:  Curr Opin Psychiatry       Date:  2014-05       Impact factor: 4.741

3.  Correlates of treatment response in depressed older adults with bipolar disorder.

Authors:  Ariel Gildengers; Curtis Tatsuoka; Christopher Bialko; Kristin A Cassidy; Rayan K Al Jurdi; Laszlo Gyulai; Benoit H Mulsant; Robert C Young; Martha Sajatovic
Journal:  J Geriatr Psychiatry Neurol       Date:  2012-03       Impact factor: 2.680

4.  Atypical antipsychotics for older adults: are they safe and effective as we once thought?

Authors:  Dilip V Jeste; Jeanne E Maglione
Journal:  J Comp Eff Res       Date:  2013-07       Impact factor: 1.744

5.  Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization.

Authors:  Hua Jin; Pei-an Betty Shih; Shahrokh Golshan; Sunder Mudaliar; Robert Henry; Danielle K Glorioso; Stephan Arndt; Helena C Kraemer; Dilip V Jeste
Journal:  J Clin Psychiatry       Date:  2012-11-27       Impact factor: 4.384

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.